|TABLE OF CONTENTSCluster's lifeOur member's newsSave the dateCalls for projectsAround our themes|
In June, Christophe Cizeron, the new president of the cluster, took up his duties to pursue the development of Lyonbiopole in connection with the strategic roadmap 3.0 which runs until the end of 2018.
For ten years, Lyonbiopole has supported the international development of its members. Once again this year, the International BIO Convention allowed us to give high visibility to the 28 actors of the delegation we have accompanied.
In June also took place the 3rd edition of the Clinical Innovation Day. A day that brought together the active forces of the Auvergne-Rhône-Alpes ecosystem around hospital-industrial collaborations.
|Christophe Cizeron, new chairman of LyonbiopoleOn Monday May 29, Lyonbiopole appointed Christophe Cizeron as its new chairman on the occasion of its Board of Directors and General Meeting. He succeeded to Philippe Archinard's 11-year presidency. This appointment bears a strong signal for the development and future of Lyonbiopole. [...]|
|3rd Clinical Innovation DayThe day, organized by Lyonbiopole and sponsored by Merck, gathered 80 participants. 8 clinicians from regional University Hospitals (Clermont-Ferrand, Lyon, Grenoble, Saint-Etienne) and from private Orthopedic Centre Santy have presented unmet medical needs in front of SMEs, large companies and academics. Regulatory topics were discussed during the afternoon with the presence of ANSM (French health agency) and CNIL (French informatic and security commission): new EU Medical Device regulation and new EU protection of personal data. The end of this clinical event was dedicated to the presentation by KOL of ongoing structuring project called UHI (University Hospital Institute). These last presentations reinforced the main objective of this event: bring together industrials and clinicians to collaborate on new R&D projects.|
|BIO San Diego - a delegation of 28 actors of innovation in Auvergne-Rhône-AlpesFrom June 19th to 22nd, the annual biotechnology event, BIO International Convention 2017, took place in San Diego. Lyonbiopole supported on this occasion the largest delegation of regional companies on the stand, within the France pavilion.|
|LUNCH BREAK PARTNERING MEETING: PIA AND JUNCKER PLANIn June, Lyonbiopole had the pleasure to welcome Jean-Christophe Dantonel, Bénédicte Garbil and Laurent Menard from the General Commissariat of Investment for a dedicated session on Programme of Investments for the Future (PIA) and Juncker plan. The event was an opportunity to highlight the funding mechanisms for SMEs offered by these programs. Lyonbiopole organized one to one meetings between CGI and 7 innovative start-ups in search of support for their development.|
|Plants Tour ACCINOV – A3P Bioproduction International CongressAs part of A3P Bioproduction International Congress which took place in Lyon from May 31th to June 1st, many players of the pharmaceutical industry came to discover the Do-It-Yourself GMP manufacturing model of Accinov for biologics through a real case study of an experimental drug developed at Accinov, and the full visit of the site.|
|Event Thermo Fisher Scientific at Accinov Thermo Fisher Scientific, organized at Accinov a day focused on the use of single-use technology for adherent cell culture. Ranging from lab scale to industrial systems, participants came to discover the technology portfolio developed by Thermo Fisher through conferences and equipment demonstration in laboratory.|
|New member3C health (Connect, Check & Care for Health), is an innovative MedTech & eHealth company with an expertise in the field of connected medical technologies. It offer solutions to health professionals aiming for better detection, prevention and overall health improvement methods. […]|
|Focus onFollowing their investment in MaaT Pharma a year ago, Biocodex is taking a further step with the French microbiotech1 company, marking a turning point in the history of the European microbiota specialist.|
|June 13th, 2017Poxel Presents New Preclinical Imeglimin Data on Improvement in Diastolic Function||June 13th, 2017GeNeuro Presents Data Supporting Role of Human Endogenous Retroviruses (HERVs) in Type 1 Diabetes||June 15th, 2017MaaT Pharma announces CE marking for its globally unique medical device|
|June 16th, 2017ENYO Pharma SA announces successful completion of EYP001 first in man Phase 1 study||June 22th, 2017Osivax announces the closing of a EUR2.7M seed funding round||June 26th, 2017Alma Bio Therapeutics and Delphi Genetics extend strategic alliance on plasmid DNA drugs|
October 10th, 2017
September 11th, 2017
November 13th, 2017
See All events
EUROPE & INTERNATIONAL
Before September 14th, 2017
Before September 14th, 2017
Before November 8th, 2017
This email has been sent automatically to [[EMAIL_TO]]. Click here to unsubscribe.